N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer diseases

Molecular and Chemical Neuropathology

Volumn 31, Issue 2, 1997, Pages 97-118

  Passani, Lucius A ^a,b   Vonsattel, Jean Paul G ^a   Carter, Ruth E ^a,b   Coyle, Joseph T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Alzheimer disease; Amino acids; Amygdala; Glia; Hippocampus; Huntington disease; N acetylaspartate; N acetylaspartylglutamate; N acetylated linked acidic dipeptidase; Striatum

Indexed keywords

ANIMALIA;

DIPEPTIDASE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN TISSUE; ENZYME ANALYSIS; HUMAN; HUNTINGTON CHOREA; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROTRANSMISSION; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMINO ACIDS; ANTIGENS, SURFACE; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CELL COUNT; DIPEPTIDASES; DIPEPTIDES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; HUNTINGTON DISEASE; NEURONS; NEUROPEPTIDES; REFERENCE VALUES;

EID: 0030842583     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815236     Document Type: Article

References (67)

1. Ball M. J. (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with aging and dementia. A quantitative study. Acta Nenropathol. 37, 111-118.
2. Blakely R. D. and Coyle J. T. (1988) The neurobiology of N-acetylaspartyl-glutamate, in International Review of Neurobiology, vol. 30 (Smythies J. R. and Bradley R., eds.), pp. 39-100, Academic, New York.
3. Blakely R. D., Robinson M. B., Thompson R. C., and Coyle J. T. (1988) Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny and the effects of lesions on N-acetylated-alpha-linked acidic dipeptidase activity. J. Neurochem. 50, 1200-1209.
4. Braak H. and Braak E. (1990) Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J. Neuropathol. Exp. Neurol. 49, 215-224.
5. Braak H., Braak E., and Bohl J. (1993) Staging of Alzheimer related cortical destruction. Eur. Neurol. 33, 403-408.
6. Bruyn G. W., Bots G., and Dom R. (1979) Huntington's chorea: current neuropathological status. Advances Neurol. 23, 83-93.
7. Chessell I. P., Francis P. T., Pangalos M. N., Pearson R. C., and Bowen D. M. (1993) Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurons. Brain Res. 632, 86-94.
8. Cudkowicz M. and Kowall N. (1990) Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann. Neurol. 27, 200-204.
9. Ebisu T., Rooney W. D., Graham S. H., Weiner M. W., and Maudsley A. A. (1994) N-acetyl-aspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus - H-1 magnetic resonance spectroscopic imaging. J. Cereb. Blood Flow Metab. 14, 373-382.
10. Goldman-Rakic P. S. and Selemon L. D. (1986) Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum, in Cerebral Cortex, vol. 5 (Jones E. G. and Peters A., eds.), pp. 447-466, Plenum, New York.
11. Graveland G. A., Williams R. S., and DiFiglia M. (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
12. Hedreen J. C., Peyser C. E., Folstein S. E., and Ross C. A. (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257-261.
13. Heinsen H., Strik M., Bauer M., Luther K., Ulmar G., Gangnus D., Jungkunz G., Eisenmenger W., and Gotz M. (1994) Cortical and striatal neuron number in Huntington's disease. Acta Neuropathol. 88, 320-333.
14. Herz E. and Funfgeld E. (1923) Zur Klinik und Pathologie der Alzheimerschen Krankheit. Arch. Psychiatr. Nervenkr. 4, 633-664.
15. Hof P. R., Cox K., and Morrison J. H. (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301, 44-54.
16. Jaarsma D., Veenma-van der Duin L., and Korf J. (1994) N-acetylaspartate and N-acetyl-aspartylglutamate levels in Alzheimer's disease post-mortem brain tissue. J. Neurol. Sci. 127, 230-233.
17. Jones E. G. (1984) Laminar distribution of cortical efferent cells, in Cerebral Cortex, vol. 1 (Peters A. and Jones E. G., eds.), pp. 521-553, Plenum, New York.
18. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1105.
19. Klunk W. E., Panchalingam K., Moossy J., McClure R. J., and Pettegrew J. W. (1992) N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 42, 1578-1585.
20. Koller K., Zaczek R., and Coyle J. T. (1984) N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142.
21. Korf J. L., Veenma-van der Duin L., Venema K., and Wolf J. H. (1991) Automated precolumn fluorescence labelling by carbodiimide activation of N-acetylaspartate and N-acetylas-partylglutamate applied to an HPLC brain tissue analysis. Anal. Biochem. 196, 350-355.
22. Kowall N. W. and Beal M. F. (1991) Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 29, 162-167.
23. Künzle H. (1975) Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca vascicularis. Brain Res. 88, 195-209.
24. Lange H. W. (1983) Quantitative changes of telencephalon, diencephalon and mesencephalon in Huntington's chorea, postencephalitic, and idiopathic parkinsonism. Verh. Anat. Ges. 75, 923-925.
25. Lowe S. L., Bowen D. M., Francis P. T., and Neary D. (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38, 571-577.
26. Meyerhoff J. L., Carter R. C., Yourick D. L., Slusher B. S., and Coyle J. T. (1992) Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate. Brain Res. 593, 140-143.
27. Mirra S. S., Hart M. N., and Terry R. D. (1993) Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch. Pathol. Lab. Med. 117, 132-144.
28. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
29. Moffett J. R., Namboodiri M. A., and Neale J. H. (1993) Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetyl-aspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J. Histochem. Cytochem. 41, 559-570.
30. Moffett J. R. and Namboodiri M. A. A. (1995) Differential distribution of N-acetyl-aspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J. Neurocytol. 24, 409-433.
31. Moffett J. R., Namboodiri M. A. A., Cangro C. B., and Neale J. H. (1991) Immunohistochemical localization of N-acetylaspartate in rat brain. NeuroReport 2, 131-134.
32. Myers R. H., Vonsattel J. P., Paskevich P. A., Kiely D. K., Stevens T. J., Cupples L. A., Richardson E. P., and Bird E. D. (1991) Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J. Neuropathol. Exp. Neurol. 50, 729-742.
33. Nadler J. V. and Cooper J. R. (1972) N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral neuvous tissues. J. Neurochem. 19, 313-319.
34. Passani L., Vonsattel J. P. and Coyle J. T. Distribution of N-acetylaspartylglutamate immunoreactivities in human brain and its alteration in neuro degenerative disorders. Brain Res., in press.
35. Perry T. L. and Hansen S. (1990) What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies. Neurology 40, 20-24.
36. Perry T. L., Hansen S., and Gandham S. S. (1981) Postmortem changes of amino compounds in human and rat brain. J. Neurochem. 36, 406-412.
37. Pope A., Amelotte J. A., Belfer H., and Nixon R. A. (1981) Protease activities in normal and schizophrenic human prefrontal cortex and white matter. Neurochem. Res. 6, 1043-1052.
38. Procter A. W., Lowe S. L., Palmer A. M., Francis P. T., Esiri M. M., Stratmann G. C., Najlerahim A., Patel A. J., Hunt A., and Bowen D. M. (1988) Topographical distribution of neurochemical changes in Alzheimer's disease. J. Neurol. Sci. 84, 125-140.
39. 3H]norepinephrine release from rat hippocampal slices. J. Pharmacol. Exp. Ther. 266, 796-803.
40. Reynolds G. P. and Pearson S. J. (1987) Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci. Lett. 78, 233-238.
41. Robinson M., Blakely S., Couto R., and Coyle J. T. (1987) Hydrolysis of the brain peptide N-acetyl-L-aspartyl-L-glutamate. J. Biol. Chem. 262, 14,498-14,506.
42. Sekiguchi M., Okamoto K., and Sakai Y. (1989) Low-concentration N-acetylaspartylglutamate suppresses the climbing fiber response of Purkinje cells in guinea pig cerebellar slices and the response to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA. Brain Res. 482, 87-96.
43. Sekiguchi M., Wada K., and Wenthold R. J. (1992) N-acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR 1) expressed in Xenopus oocytes. FEBS Lett. 311, 285-289.
44. Selemon L. D. and Goldman-Rakic P. (1985) Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J. Neurosci. 5, 776-794.
45. Simmons M. L., Frondoza C. G., and Coyle J. T. (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45.
46. Sotrel A., Paskevich P. A., Kiely D. K., Bird E. D., Williams R. S., and Myers R. H. (1991) Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 41, 1117-1123.
47. Sotrel A., Williams R. S., Kaufmann W. E., and Myers R. H. (1993) Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: a quantitative Golgi study. Neurology 43, 2088-2096.
48. Stauch-Slusher B., Tsai G., Voo G., and Coyle J. T. (1992) Immunohistochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated-alpha-linked acidic dipeptidase (NAALADase). J. Comp. Neurol. 315, 217-229.
49. Swaab D. F. and Uylings H. B. M. (1987) Density measures: parameters to avoid. Neurobiol. Aging 8, 574-576.
50. Terry R. D., Peck A., De Terese R., Schlechter R., and Horoupian D. S. (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10, 184-192.
51. Tieman S. B., Neale J. H., and Tieman D. G. (1991) N-acetylaspartylglutamate immunoreactivity in neurons of the monkey's visual pathway. J. Comp. Neurol. 313, 45-64.
52. Tsai G. and Coyle J. T. (1995) N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46, 531-540.
53. Tsai G., Passani L., Slusher B., Carter R., Kleinman J., and Coyle J. (1995) Changes of excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52, 829-836.
54. Tsai G., Slusher B., Sim L., Hedreen J. C., Rothstein J. D., Kuncl R., and Coyle J. T. (1991) Reductions in acidic amino acids and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis CNS. Brain Res. 556, 151-156.
55. Tsai G., Stauch B. L., Vornov J. J., Deshpande J. K., and Coyle J. T. (1990) Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res. 518, 313-316.
56. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neuronal cell types. J. Neurosci. 13, 981-989.
57. Uzman L. L., Rumley M. K., and Van der Noort S. (1962) Properties and classification of some brain peptidases. J. Neurochem. 9, 241-252.
58. Vereecken T. H. L. G., Vogels O. J. M., and Nieuwenhuys R. (1994) Neuron loss and shrinkage in the amygdala in Alzheimer's disease. Neurobiol. Aging 15, 45-54.
59. Vonsattel J., Aizawa H., Ge P., DiFiglia M., McKee A. C., MacDonald M., Gusella J. F., Landwehrmeyer B., Bird E. D., Richardson E. P., Jr., and Hedley-Whyte E. T. (1995) An improved approach to prepare human brains for research. J. Neuropath. Exp. Neurol. 54, 42-56.
60. Vonsattel J.-P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., and Richardson E. P. (1985) Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44, 559-577.
61. West M. J. (1994) Advances in the study of age-related neuron loss. Seminars Neurosci. 6, 403-411.
62. Westbrook G. L., Mayer M. L., Namboodiri M. A., and Neale J. H. (1986) High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J. Neurosci. 6, 3385-3392.
63. Williamson L. C. and Neale J. H. (1988a) Ultrastructural localization of N-acetylaspartylglutamate in synaptic vesicles of retinal neurons. Brain Res. 456, 375-381.
64. Williamson L. C. and Neale J. H. (1988b) Calcium-dependent release of N-acetylaspartylglutamate from retinal neurons upon depolarization. Brain Res. 475, 151-155.
65. Wroblewska B., Wroblewski J. T., Saab O. H., and Neale J. H. (1993) N-acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. J. Neurochem. 61, 943-948.
66. Zollinger M., Amsler U., Do K. Q., Streit P., and Ceunod M. (1988) Release of N-acetyl-aspartylglutamate on depolarization of rat brain slices. J. Neurochem. 51, 1919-1923.
67. Zollinger M., Brauchlitheotokis J., Gutteckamsler U., Do K. Q., Streit P., and Cuenod M. (1994) Release of N-acetylaspartylglutamate from slices of rat cerebellum, striatum, and spinal cord, and the effect of climbing fiber deprivation. J. Neurochem. 63, 1133-1142.